Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 May;107(5):391–396. doi: 10.1289/ehp.99107391

The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study.

S W Tsaih 1, J Schwartz 1, M L Lee 1, C Amarasiriwardena 1, A Aro 1, D Sparrow 1, H Hu 1
PMCID: PMC1566410  PMID: 10210695

Abstract

Plasma is the component of blood from which lead is free to cross cell membranes and cause organ toxicity. Plasma lead levels, however, are extremely low and difficult to measure. Urinary lead originates from plasma lead that has been filtered at the glomerular level; thus, urinary lead adjusted for glomerular filtration rate serves as a proxy for plasma lead levels. In this investigation we examined the interrelationships of lead levels in whole blood corrected by hematocrit [i.e., erythrocyte lead (EPb)], trabecular bone (TBoPb), cortical bone (CBoPb), and urine excreted over 24 hr (UPb); all samples were obtained from 71 middle-aged and elderly men with no known occupational lead exposures. Lead was measured by graphite furnace atomic absorption spectroscopy (blood), K-X-ray fluorescence (bone), and inductively coupled plasma mass spectroscopy (urine). Lead levels were generally low, with mean EPb, TBoPb, and CBoPb values of 13.8, 31.1, and 21.7 microg/g, respectively, and a median UPb value of 6.15 microg/day. In generalized additive models adjusted for body weight and creatinine clearance rate, both EPb and bone lead variables remained independently and significantly associated with UPb. This finding suggests that bone influences plasma lead in a manner that is independent of the influence of erythrocytic lead on plasma lead. Thus, the superiority of bone lead over blood lead in predicting some chronic forms of toxicity may be mediated through bone's influence on plasma lead. In addition, this study suggests that measurement of urinary lead might be useful as a proxy for plasma lead levels in studies of lead toxicity.

Full text

PDF
391

Images in this article

394Figure 1
on p.394
394Figure 2
on p.394
395Figure 3
on p.395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aro A. C., Todd A. C., Amarasiriwardena C., Hu H. Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol. 1994 Dec;39(12):2263–2271. doi: 10.1088/0031-9155/39/12/009. [DOI] [PubMed] [Google Scholar]
  2. Barry P. S., Mossman D. B. Lead concentrations in human tissues. Br J Ind Med. 1970 Oct;27(4):339–351. doi: 10.1136/oem.27.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergdahl I. A., Schütz A., Gerhardsson L., Jensen A., Skerfving S. Lead concentrations in human plasma, urine and whole blood. Scand J Work Environ Health. 1997 Oct;23(5):359–363. doi: 10.5271/sjweh.232. [DOI] [PubMed] [Google Scholar]
  4. Bergdahl I. A., Skerfving S. Partition of circulating lead between plasma and red cells does not seem to be different for internal and external sources of lead. Am J Ind Med. 1997 Sep;32(3):317–318. doi: 10.1002/(sici)1097-0274(199709)32:3<317::aid-ajim22>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  5. Bernard S. R. Dosimetric data and metabolic model for lead. Health Phys. 1977 Jan;32(1):44–46. [PubMed] [Google Scholar]
  6. Burger D. E., Milder F. L., Morsillo P. R., Adams B. B., Hu H. Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci. 1990;55:287–292. doi: 10.1007/978-1-4613-1473-8_39. [DOI] [PubMed] [Google Scholar]
  7. Cake K. M., Bowins R. J., Vaillancourt C., Gordon C. L., McNutt R. H., Laporte R., Webber C. E., Chettle D. R. Partition of circulating lead between serum and red cells is different for internal and external sources of lead. Am J Ind Med. 1996 May;29(5):440–445. doi: 10.1002/(SICI)1097-0274(199605)29:5<440::AID-AJIM2>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  8. Cavalleri A., Minoia C., Pozzoli L., Baruffini A. Determination of plasma lead levels in normal subjects and in lead-exposed workers. Br J Ind Med. 1978 Feb;35(1):21–26. doi: 10.1136/oem.35.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheng Y., Willett W. C., Schwartz J., Sparrow D., Weiss S., Hu H. Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol. 1998 Jun 15;147(12):1162–1174. doi: 10.1093/oxfordjournals.aje.a009415. [DOI] [PubMed] [Google Scholar]
  10. Christoffersson J. O., Ahlgren L., Schütz A., Skerfving S., Mattsson S. Decrease of skeletal lead levels in man after end of occupational exposure. Arch Environ Health. 1986 Sep-Oct;41(5):312–318. doi: 10.1080/00039896.1986.9936703. [DOI] [PubMed] [Google Scholar]
  11. Christoffersson J. O., Schütz A., Ahlgren L., Haeger-Aronsen B., Mattsson S., Skerfving S. Lead in finger-bone analysed in vivo in active and retired lead workers. Am J Ind Med. 1984;6(6):447–457. doi: 10.1002/ajim.4700060608. [DOI] [PubMed] [Google Scholar]
  12. Erkkilä J., Armstrong R., Riihimäki V., Chettle D. R., Paakkari A., Scott M., Somervaille L., Starck J., Kock B., Aitio A. In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure. Br J Ind Med. 1992 Sep;49(9):631–644. doi: 10.1136/oem.49.9.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Franklin C. A., Inskip M. J., Baccanale C. L., Edwards C. M., Manton W. I., Edwards E., O'flaherty E. J. Use of sequentially administered stable lead isotopes to investigate changes in blood lead during pregnancy in a nonhuman primate (Macaca fascicularis). Fundam Appl Toxicol. 1997 Oct;39(2):109–119. doi: 10.1006/faat.1997.2355. [DOI] [PubMed] [Google Scholar]
  14. Gerhardsson L., Attewell R., Chettle D. R., Englyst V., Lundström N. G., Nordberg G. F., Nyhlin H., Scott M. C., Todd A. C. In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health. 1993 May-Jun;48(3):147–156. doi: 10.1080/00039896.1993.9940813. [DOI] [PubMed] [Google Scholar]
  15. Goldman R. H., White R., Kales S. N., Hu H. Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med. 1994 Mar;25(3):417–424. doi: 10.1002/ajim.4700250309. [DOI] [PubMed] [Google Scholar]
  16. González-Cossío T., Peterson K. E., Sanín L. H., Fishbein E., Palazuelos E., Aro A., Hernández-Avila M., Hu H. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics. 1997 Nov;100(5):856–862. doi: 10.1542/peds.100.5.856. [DOI] [PubMed] [Google Scholar]
  17. Gordon C. L., Chettle D. R., Webber C. E. An improved instrument for the in vivo detection of lead in bone. Br J Ind Med. 1993 Jul;50(7):637–641. doi: 10.1136/oem.50.7.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gulson B. L., Calder I. C. Lead mobilisation during pregnancy. Med J Aust. 1995 Oct 16;163(8):447–447. doi: 10.5694/j.1326-5377.1995.tb124682.x. [DOI] [PubMed] [Google Scholar]
  19. Gulson B. L., Cameron M. A., Smith A. J., Mizon K. J., Korsch M. J., Vimpani G., McMichael A. J., Pisaniello D., Jameson C. W., Mahaffey K. R. Blood lead-urine lead relationships in adults and children. Environ Res. 1998 Aug;78(2):152–160. doi: 10.1006/enrs.1997.3810. [DOI] [PubMed] [Google Scholar]
  20. Gulson B. L., Jameson C. W., Mahaffey K. R., Mizon K. J., Korsch M. J., Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med. 1997 Jul;130(1):51–62. doi: 10.1016/s0022-2143(97)90058-5. [DOI] [PubMed] [Google Scholar]
  21. Gulson B. L., Mahaffey K. R., Jameson C. W., Mizon K. J., Korsch M. J., Cameron M. A., Eisman J. A. Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy. J Lab Clin Med. 1998 Apr;131(4):324–329. doi: 10.1016/s0022-2143(98)90182-2. [DOI] [PubMed] [Google Scholar]
  22. Gulson B. L., Mahaffey K. R., Mizon K. J., Korsch M. J., Cameron M. A., Vimpani G. Contribution of tissue lead to blood lead in adult female subjects based on stable lead isotope methods. J Lab Clin Med. 1995 Jun;125(6):703–712. [PubMed] [Google Scholar]
  23. Hernandez-Avila M., Gonzalez-Cossio T., Palazuelos E., Romieu I., Aro A., Fishbein E., Peterson K. E., Hu H. Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect. 1996 Oct;104(10):1076–1082. doi: 10.1289/ehp.961041076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hernández-Avila M., Smith D., Meneses F., Sanin L. H., Hu H. The influence of bone and blood lead on plasma lead levels in environmentally exposed adults. Environ Health Perspect. 1998 Aug;106(8):473–477. doi: 10.1289/ehp.106-1533211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hirata M., Yoshida T., Miyajima K., Kosaka H., Tabuchi T. Correlation between lead in plasma and other indicators of lead exposure among lead-exposed workers. Int Arch Occup Environ Health. 1995;68(1):58–63. doi: 10.1007/BF01831634. [DOI] [PubMed] [Google Scholar]
  26. Hu H., Aro A., Payton M., Korrick S., Sparrow D., Weiss S. T., Rotnitzky A. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA. 1996 Apr 17;275(15):1171–1176. [PubMed] [Google Scholar]
  27. Hu H., Milder F. L., Burger D. E. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure. Arch Environ Health. 1990 Nov-Dec;45(6):335–341. doi: 10.1080/00039896.1990.10118752. [DOI] [PubMed] [Google Scholar]
  28. Hu H., Payton M., Korrick S., Aro A., Sparrow D., Weiss S. T., Rotnitzky A. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study. Am J Epidemiol. 1996 Oct 15;144(8):749–759. doi: 10.1093/oxfordjournals.aje.a008999. [DOI] [PubMed] [Google Scholar]
  29. Hu H., Rabinowitz M., Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998 Jan;106(1):1–8. doi: 10.1289/ehp.981061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Inskip M. J., Franklin C. A., Baccanale C. L., Manton W. I., O'Flaherty E. J., Edwards C. M., Blenkinsop J. B., Edwards E. B. Measurement of the flux of lead from bone to blood in a nonhuman primate (Macaca fascicularis) by sequential administration of stable lead isotopes. Fundam Appl Toxicol. 1996 Oct;33(2):235–245. doi: 10.1006/faat.1996.0161. [DOI] [PubMed] [Google Scholar]
  31. Keller C. A., Doherty R. A. Bone lead mobilization in lactating mice and lead transfer to suckling offspring. Toxicol Appl Pharmacol. 1980 Sep 15;55(2):220–228. doi: 10.1016/0041-008x(80)90083-6. [DOI] [PubMed] [Google Scholar]
  32. Kim R., Aro A., Rotnitzky A., Amarasiriwardena C., Hu H. K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol. 1995 Sep;40(9):1475–1485. doi: 10.1088/0031-9155/40/9/007. [DOI] [PubMed] [Google Scholar]
  33. Korrick S. A., Hunter D. J., Rotnitzky A., Hu H., Speizer F. E. Lead and hypertension in a sample of middle-aged women. Am J Public Health. 1999 Mar;89(3):330–335. doi: 10.2105/ajph.89.3.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Landrigan P. J., Todd A. C. Direct measurement of lead in bone. A promising biomarker. JAMA. 1994 Jan 19;271(3):239–240. [PubMed] [Google Scholar]
  35. Leggett R. W. An age-specific kinetic model of lead metabolism in humans. Environ Health Perspect. 1993 Dec;101(7):598–616. doi: 10.1289/ehp.93101598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Manton W. I., Cook J. D. High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid. Br J Ind Med. 1984 Aug;41(3):313–319. doi: 10.1136/oem.41.3.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Manton W. I. Total contribution of airborne lead to blood lead. Br J Ind Med. 1985 Mar;42(3):168–172. doi: 10.1136/oem.42.3.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Marcus A. H. Multicompartment kinetic model for lead. III. Lead in blood plasma and erythrocytes. Environ Res. 1985 Apr;36(2):473–489. doi: 10.1016/0013-9351(85)90039-8. [DOI] [PubMed] [Google Scholar]
  39. Nilsson U., Attewell R., Christoffersson J. O., Schütz A., Ahlgren L., Skerfving S., Mattsson S. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol Toxicol. 1991 Jun;68(6):477–484. doi: 10.1111/j.1600-0773.1991.tb01273.x. [DOI] [PubMed] [Google Scholar]
  40. O'Flaherty E. J., Hammond P. B., Lerner S. I. Dependence of apparent blood lead half-life on the length of previous lead exposure in humans. Fundam Appl Toxicol. 1982 Jan-Feb;2(1):49–54. doi: 10.1016/s0272-0590(82)80064-x. [DOI] [PubMed] [Google Scholar]
  41. O'Flaherty E. J. Physiologic changes during growth and development. Environ Health Perspect. 1994 Dec;102 (Suppl 11):103–106. doi: 10.1289/ehp.94102s11103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. O'Flaherty E. J. Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans. Toxicol Appl Pharmacol. 1993 Jan;118(1):16–29. doi: 10.1006/taap.1993.1004. [DOI] [PubMed] [Google Scholar]
  43. Ong C. N., Lee W. R. Distribution of lead-203 in human peripheral blood in vitro. Br J Ind Med. 1980 Feb;37(1):78–84. doi: 10.1136/oem.37.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ong C. N., Lee W. R. Interaction of calcium and lead in human erythrocytes. Br J Ind Med. 1980 Feb;37(1):70–77. doi: 10.1136/oem.37.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pirkle J. L., Brody D. J., Gunter E. W., Kramer R. A., Paschal D. C., Flegal K. M., Matte T. D. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES) JAMA. 1994 Jul 27;272(4):284–291. [PubMed] [Google Scholar]
  46. Rabinowitz M. B., Wetherill G. W., Kopple J. D. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest. 1976 Aug;58(2):260–270. doi: 10.1172/JCI108467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rabinowitz M. B., Wetherill G. W., Kopple J. D. Lead metabolism in the normal human: stable isotope studies. Science. 1973 Nov 16;182(4113):725–727. doi: 10.1126/science.182.4113.725. [DOI] [PubMed] [Google Scholar]
  48. Rabinowitz M. B., Wetherill G. W., Kopple J. D. Magnitude of lead intake from respiration by normal man. J Lab Clin Med. 1977 Aug;90(2):238–248. [PubMed] [Google Scholar]
  49. Schroeder H. A., Tipton I. H. The human body burden of lead. Arch Environ Health. 1968 Dec;17(6):965–978. doi: 10.1080/00039896.1968.10665354. [DOI] [PubMed] [Google Scholar]
  50. Schwartz J. Air pollution and hospital admissions for the elderly in Birmingham, Alabama. Am J Epidemiol. 1994 Mar 15;139(6):589–598. doi: 10.1093/oxfordjournals.aje.a117048. [DOI] [PubMed] [Google Scholar]
  51. Schwartz J. Air pollution and hospital admissions for the elderly in Detroit, Michigan. Am J Respir Crit Care Med. 1994 Sep;150(3):648–655. doi: 10.1164/ajrccm.150.3.8087333. [DOI] [PubMed] [Google Scholar]
  52. Schütz A., Skerfving S., Christoffersson J. O., Ahlgren L., Mattson S. Lead in vertebral bone biopsies from active and retired lead workers. Arch Environ Health. 1987 Nov-Dec;42(6):340–346. doi: 10.1080/00039896.1987.9934356. [DOI] [PubMed] [Google Scholar]
  53. Silbergeld E. K., Sauk J., Somerman M., Todd A., McNeill F., Fowler B., Fontaine A., van Buren J. Lead in bone: storage site, exposure source, and target organ. Neurotoxicology. 1993 Summer-Fall;14(2-3):225–236. [PubMed] [Google Scholar]
  54. Silbergeld E. K., Schwartz J., Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res. 1988 Oct;47(1):79–94. doi: 10.1016/s0013-9351(88)80023-9. [DOI] [PubMed] [Google Scholar]
  55. Skerfving S., Ahlgren L., Christoffersson J. O., Haeger-Aronsen B., Mattsson S., Schütz A. Metabolism of inorganic lead in occupationally exposed humans. Arh Hig Rada Toksikol. 1983 Dec;34(4):341–350. [PubMed] [Google Scholar]
  56. Smith D. R., Ilustre R. P., Osterloh J. D. Methodological considerations for the accurate determination of lead in human plasma and serum. Am J Ind Med. 1998 May;33(5):430–438. doi: 10.1002/(sici)1097-0274(199805)33:5<430::aid-ajim2>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  57. Smith D. R., Osterloh J. D., Flegal A. R. Use of endogenous, stable lead isotopes to determine release of lead from the skeleton. Environ Health Perspect. 1996 Jan;104(1):60–66. doi: 10.1289/ehp.9610460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Symanski E., Hertz-Picciotto I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am J Epidemiol. 1995 Jun 1;141(11):1047–1058. doi: 10.1093/oxfordjournals.aje.a117369. [DOI] [PubMed] [Google Scholar]
  59. Todd A. C., McNeill F. E., Palethorpe J. E., Peach D. E., Chettle D. R., Tobin M. J., Strosko S. J., Rosen J. C. In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies. Environ Res. 1992 Apr;57(2):117–132. doi: 10.1016/s0013-9351(05)80073-8. [DOI] [PubMed] [Google Scholar]
  60. Wedeen R. P., Malik D. K., Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med. 1979 Jan;139(1):53–57. [PubMed] [Google Scholar]
  61. deSilva P. E. Determination of lead in plasma and studies on its relationship to lead in erythrocytes. Br J Ind Med. 1981 Aug;38(3):209–217. doi: 10.1136/oem.38.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES